VIROVEK'S

BAC-TO-AAV TECHNOLOGY
FOR LARGE SCALE AAV PRODUCTION

Avalanche Biotechnologies, Inc. and Lonza will use Virovek’s patented technology

San Francisco, California, and Houston, TX, May 16, 2012

Avalanche Biotechnologies, Inc. and Lonza announced their major global manufacturing collaboration to use Virovek’s patented technologyto produce AAV vectors for gene therapy studies.